Molecular and Cellular Biochemistry

, Volume 131, Issue 2, pp 99–104 | Cite as

Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA)

  • Mohammed Kalimi
  • Yanal Shafagoj
  • Roger Loria
  • David Padgett
  • William Regelson

Key words

dehydroepiandrosterone glucocorticoids anti-glucocorticoids 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kalimi M, Regelson W: The biologic role of dehydroepiandrosterone (DHEA). Walter de Gruyter New York, 1990Google Scholar
  2. 2.
    Lardy H, Stratman F: Hormones, thermogenesis and obesity. Elsevier, New York, 1989Google Scholar
  3. 3.
    Adrenal androgens in clinical medicine, pp 118–134, Academic Press, San Diego, 1989Google Scholar
  4. 4.
    Baulieu E, Corpechot C, Dray F, Emiolozzi R et al.: An adrenal secreted ‘androgen’: Dehydroisoandrosterone sulfate. Its metabolism, and a tentative generalization on the metabolism of other steroid conjugates in man. Rec Prog Horm Res 21:411–500, 1965Google Scholar
  5. 5.
    Migeon CJ, Plager JE: Identification and isolation of dehydroisoandrosterone from peripheral human plasma. J Biol Chem 209: 767–772, 1954Google Scholar
  6. 6.
    Hobkirk R: Steroid sulfotransferases and steroid sulfate sulfatases: characteristics and biological roles. Can J Biochem 63:1127–1144, 1985Google Scholar
  7. 7.
    Daynes RA, Dudley DJ, Araneo BA: Regulation of murine Iymphokine productionin vivo. Dehydroepiandrosterone is a natural enhancer of IL-2 synthesis by helper T-cells. Europ J Immuno 20: 793–801, 1980Google Scholar
  8. 8.
    Leiter E, Beamer W, Coleman D, Longcope C: Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: Relationship to antihyperglycemic effects. Metabolism 36: 863–869, 1987Google Scholar
  9. 9.
    De Peretti E, Forest MG: Pattern of plasma dehydroepiandrosterone sulfate levels in human from birth to adulthood: Evidence for testicular production. J Clin Endocrinology Metab 47:572–577, 1978Google Scholar
  10. 10.
    Mann D, Castracane D, McLaughlin F et al.: Developmental patterns of serum luteinizing hormone, gonadal and adrenal steroids in the sooty mangabey (Cercocebus atys). Biol Repro 28:279–284, 1983Google Scholar
  11. 11.
    Purifoy FE, Koopmans LH, Tatum RW: Steroid hormones and aging: Free testosterone and androstenedione in normal females aged 20–87 years. Human Biol 52:181–191, 1980Google Scholar
  12. 12.
    Loria RM, Inge TH, Cook S, Szakal A, Regelson W: Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J Med Virology 26:301–314, 1988Google Scholar
  13. 13.
    Milewich L, Shaw CB, Sondheimer RD: Steroid metabolism by epidermal keratinocytes. Ann NY Acad Sci 548:66–89, 1988Google Scholar
  14. 14.
    Loria R, Padgett D: Androstenediol regulates systemic resistance against lethal infections in mice. Archives of Virology: 103–115, 1992Google Scholar
  15. 15.
    Baulieu EE, Robel P: Neurosteroids: A new brain function? J Steroid Biochem Mol Biol 27:305–403, 1990Google Scholar
  16. 16.
    Robel P, Baulieu EE, Corpechot C et al.: Neurosteroids: 3β-Hydroxy-5 derivatives in rat and monkey brain. J Steroid Biochem Mol Biol 27:649–655, 1982Google Scholar
  17. 17.
    De Marinis L, Mancini A, D:Arnico C, Calabro F et al.: Hyperandrogenism originating from the adrenal gland. Current observations on a clinical case. Minerva Ginecol 41:129–140, 1989Google Scholar
  18. 18.
    Taubert H: The ovary suppression test in the evaluation of hyperandrogenemia. Gynecol Endocrinol 4:109–118, 1990Google Scholar
  19. 19.
    Braithwaite SS, Collins S, Prinz R et al.: Decreased dehydroepian-drosterone sulfate in pigmented nodular adrenal dysplasia. Clin Chem 35:2216–2219, 1989Google Scholar
  20. 20.
    Pang S, Legido A, Levine L, Temeck J, New M: Adrenal androgen response tometyrapone, adrenocorticotropin and corticotropin-releasing hormone stimulation in children with hypopituitarism. J Clin Endocrinol Metab 65:282–289, 1987Google Scholar
  21. 21.
    Leblhuber F, Windhager E, Steinparz F, Dienstl E, Reisecker F, Rittmannsberger H: Dehydroepiandrosterone-sulfate (DHEA-S) serum levels in normal aging and Alzheimer's disease. Age 26: 116–118 1991Google Scholar
  22. 22.
    Leblhuber F, Windhager E, Neubauer C, Weber M, Reisecker F, Dienstl E: Antiglucocorticoid effects of DHEA-S in Alzheimer's disease [letter]. Am J Psychiatry 149:1125–1126, 1992Google Scholar
  23. 23.
    Wolkowitz O, Reus V, Manfredi F, Roberts E: Dr. Wolkowitz and associate reply. Am J Psychiatry 149:1126, 1992Google Scholar
  24. 24.
    Daynes RA, Araneo BA: Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukine-2 and interleukine-4. Europ J Immuno 19:2319–2325, 1990Google Scholar
  25. 25.
    Daynes R, Dudley D, Araneo B: Regulation of murine lymphokine productionin vivo. II Dehydroepiandrosterone is a natural enhancer of IL-2 synthesis by helper T cells. Europ J Immuno 20: 793–801, 1990Google Scholar
  26. 26.
    Daynes RA, Araneo BA, Dowel TA et al.: Regulation of murine lymphokine productionin vivo. III. The lymphoid microenvironment exerts regulatory influences over T helper function. J Exp Med 171:979–996, 1990Google Scholar
  27. 27.
    Blauer K, Poth M, Rogers WM, Bernton EW: Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129:3174–3179, 1991Google Scholar
  28. 28.
    Ramusseen K, Martin E, Arrowood M, Healey M: J Parasitol 38: 157S-159S, 1991Google Scholar
  29. 29.
    May M, Holmes E, Rogers W, Poth M: Protection from glucocorticoid-induced thymic involution by dehydroepiandrosterone. Life Sciences 46:1627–1631, 1990Google Scholar
  30. 30.
    Riley V: Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 212:1100–1109, 1981Google Scholar
  31. 31.
    McIntosh M, Berdanier C: Differential effects of adrenalectomy and starvation-refeeding on hepatic lipogenic responses to dehydroepiandrosterone and glucocorticoid in DHE and Sprague-Dawley rats. J Nutr 110:1011–1017, 1988Google Scholar
  32. 32.
    Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:19–27, 1975Google Scholar
  33. 33.
    Rubin C, Mirsch A, Fung C, Rosen M: Development of hormone receptors and hormonal responsivenessin vitro. J Biol Chem 253: 7570–7578, 1978Google Scholar
  34. 34.
    Gordon GB, Shantz LM, Talalay P: Modulation of growth, differentiation, and carcinogenesis by dehydroepiandrosterone. Advances in Enzymology Regulation 26:355–382, 1987Google Scholar
  35. 35.
    Coleman DL: Dehydroepiandrosterone (DHEA) and diabetic syndromes in mice. In: Kalimi M, Regelson W (eds) The biologic role of dehydroepiandrosterone, pp 179–206, Walter de Gruyter, New York, 1990Google Scholar
  36. 36.
    Shafagoj Y, Opoku J, Qureshi D, Regelson W, Kalimi M: Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats. Am J Physiol 263:E210-E213, 1992Google Scholar
  37. 37.
    Shafagoj Y, Witorsch R, Sholley M, Regelson W, Kalimi M: Dehydroepiandrosterone-dexamethasone interactions on Nb2 lymphoma cell proliferation. Life Sciences Advances- Steroid Biochemistry (In Press), 1993Google Scholar
  38. 38.
    Wright E, Porter J, Brown E, Svec F: DHEA acts as an antiglucocorticoid in Zucker fatty rat. Int J Obesity 16:579–583, 1992Google Scholar
  39. 39.
    Browne E, Wright B, Porter J, Svec F: Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sciences 303:366–371, 1992Google Scholar
  40. 40.
    Kalimi M, Regelson M: Physicochemical characterization of (3H) DHEA binding in rat liver. Biochem Biophy Res Comm: 22–29, 1988Google Scholar
  41. 41.
    Meilke A, Dorchuck R, Araneo B, Stringham J, Evans T, Spruance S, Daynes R: The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 42:293–304, 1992Google Scholar
  42. 42.
    Kalimi M, Opoku J, Lu R et al.: Studies of the biochemical action and mechanism of dehydroepiandrosterone. In: Kalimi M, Regelson W (eds) The biologic role of dehydroepiandrosterone. pp 397–404, Walter de Gruyter. New York, 1990Google Scholar
  43. 43.
    Crudo D: Downregulation of glucocorticoid receptors by dehydroepiandrosterone. 71st Annual Meeting of the Endocrine Society, Seattle, WA, p 386 (Abst), 1989Google Scholar
  44. 44.
    Imai A, Ohno T, Tamaya T: Dehydroepiandrosterone sulfate-binding sites in plasma membrane from human uterine cervical fibroblasts. Experientia 48:999–1002, 1992Google Scholar
  45. 45.
    Regelson W, Loria R, Kalimi M: Hormonal Intervention: ‘buffer hormones’ or ‘state dependency’. The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging. Ann New York Acad Sci 521:260–273, 1988Google Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • Mohammed Kalimi
    • 1
  • Yanal Shafagoj
    • 1
  • Roger Loria
    • 1
  • David Padgett
    • 1
  • William Regelson
    • 1
  1. 1.Departments of Physiology, Anatomy, Microbiology and Immunology and MedicineMedical College of VirginiaRichmondUSA

Personalised recommendations